Key Details to Know Before Subscribing to Emcure Pharma IPO

Key Details to Know Before Subscribing to Emcure Pharma IPO

Emcure Pharma IPO: Key Details to Know

Offer Details:

IPO Opens: July 3, 2024

IPO Closes: July 5, 2024

Issue Size: ₹1,952.03 crore, comprising:

  • Fresh issue: ₹800 crore
  • Offer for sale (OFS): ₹1,152.03 crore

Lot Size and Price Band:

Lot Size: 14 shares

Price Band: ₹960 – ₹1,008 per share

Reservation and Allocation:

  • 50% of the IPO reserved for Qualified Institutional Buyers (QIBs)
  • 35% reserved for retail investors
  • 15% reserved for non-institutional investors

Company Profile:

  • Engaged in developing, manufacturing, and marketing pharmaceutical products
  • Focus on therapeutic areas like oncology, cardiovascular, and HIV
  • Strong presence in European and Canadian markets
  • 13th largest pharmaceutical company in India by domestic sales


  • Revenue for FY24: ₹6,658 crore
  • Profit after tax (PAT) for FY24: ₹527.58 crore
  • Strong net worth growth of 18% in FY24

Use of Proceeds:

  • Repayment of borrowings: ₹600 crore
  • General corporate purposes: ₹200 crore

Key Considerations:

  • Strong market position in several therapeutic areas
  • Experienced management team and supportive investors like Bain Capital
  • Subject to extensive government regulations
  • Competition from established pharmaceutical companies
  • Negative cash and cash equivalents in recent years

Brokerage Firm IPO Review:

Reviews not yet available.

IPO Timeline:

Anchor Investor Offer: July 2, 2024

Subscription Period: July 3-5, 2024

Allotment Date: July 8, 2024

Listing Date: July 10, 2024


This article is for informational purposes only and should not be construed as investment advice. Investors should consult with registered investment advisors or other qualified professionals before making any investment decisions.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *